Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dukart

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Intelligence & Clinical Pharmacy|March 1, 1985
Comment on mitoxantroneG DuKart, M J Iatropoulos, A Yacobi
Investigational New Drugs|January 1, 1985
Mitoxantrone: an overview of safety and toxicityL E Posner, G Dukart, J Goldberg, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone in refractory acute leukemia in children: a phase I studyK A Starling, A F Mulne, T S Vats, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone in malignant lymphomasR A Gams, J W Keller, H M Golomb, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantroneZ A Arlin, E Berman, S Jhanwar, et al.
Journal of Clinical Pharmacology|August 1, 1994
Dose proportionality of bisoprolol enantiomers in humans after oral administration of the racemateA Dutta, R Lanc, E Begg, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone in malignant lymphomaR A Gams, S Bryan, G Dukart, et al.
Investigational New Drugs|January 1, 1985
A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancerJ C Allegra, T Woodcock, S Woolf, et al.
Journal of Chemotherapy (Florence, Italy)|March 24, 2009
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspectiveJ Teras, J Gardovskis, T Vaasna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancerI C Henderson, J C Allegra, T Woodcock, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Intelligence & Clinical Pharmacy|March 1, 1985
Comment on mitoxantroneG DuKart, M J Iatropoulos, A Yacobi
Investigational New Drugs|January 1, 1985
Mitoxantrone: an overview of safety and toxicityL E Posner, G Dukart, J Goldberg, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone in refractory acute leukemia in children: a phase I studyK A Starling, A F Mulne, T S Vats, et al.
Cancer Treatment Reviews|December 1, 1983
Mitoxantrone in malignant lymphomasR A Gams, J W Keller, H M Golomb, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantroneZ A Arlin, E Berman, S Jhanwar, et al.
Journal of Clinical Pharmacology|August 1, 1994
Dose proportionality of bisoprolol enantiomers in humans after oral administration of the racemateA Dutta, R Lanc, E Begg, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone in malignant lymphomaR A Gams, S Bryan, G Dukart, et al.
Investigational New Drugs|January 1, 1985
A randomized trial comparing mitoxantrone with doxorubicin in patients with stage IV breast cancerJ C Allegra, T Woodcock, S Woolf, et al.
Journal of Chemotherapy (Florence, Italy)|March 24, 2009
Overview of tigecycline efficacy and safety in the treatment of complicated skin and skin structure infections - a European perspectiveJ Teras, J Gardovskis, T Vaasna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1989
Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancerI C Henderson, J C Allegra, T Woodcock, et al.
Pageof 2